SELICRELUMAB

UNII:	0O39RGI33V
Formula:
Preferred Substance Name:	SELICRELUMAB

1622140-49-1
CD40 AGONIST MONOCLONAL ANTIBODY CP-870,893
CP 870,893
CP 870,893 [WHO-DD]
CP-870,893
CP-870893
HUMAN MOAB (IGG2) (CP-870,893) TO CD40 RECEPTOR
IMMUNOGLOBULIN G2, ANTI-(HUMAN CD40 ANTIGEN RECEPTOR) (HUMAN MONOCLONAL IMAB CD40 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IMAB CD40 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5 (CD40 ANTIGEN)HOMO SAPIENS MONOCLONAL ANTIBODY.GAMMA.2 HEAVY CHAIN (1-452) (HOMO SAPIENS VH (IGHV1-2*02 (98%) (IGHD)-IGHJ4*01) (8.8.19) (1-126) -HOMO SAPIENS IGHG2*01 (127-452)) (140-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-12*01 (95%) IGKJ4*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')), DIMER (228-228'':229-229'':232-232'':235-235'')-TETRAKISDISULFIDE
NG-350A EXPRESSED ANTI-CD40 ANTIBODY
RG7876
RG-7876
RO-7009789
SELICRELUMAB [INN]
SELICRELUMAB [USAN]
SELICRELUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SELICRELUMAB

Synonyms and Mappings

Resources